epigallocatechin gallate has been researched along with coenzyme q10 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Mohaimeed, N; Al-Shaikh, Y; Arjumand, S; Banu, N; Fatima, S; Hasan, S; Tyagi, P | 1 |
| Aljaser, FS; Alrashed, M; Alsharidah, AS; AlSubki, RA; Banu, N; Fatima, S; Suhail, N; Wasi, S | 1 |
2 other study(ies) available for epigallocatechin gallate and coenzyme q10
| Article | Year |
|---|---|
Combined treatment of epigallocatechin gallate and Coenzyme Q10 attenuates cisplatin-induced nephrotoxicity via suppression of oxidative/nitrosative stress, inflammation and cellular damage.
Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cisplatin; Inflammation; Kidney; Male; Nitrosation; Oxidative Stress; Rats; Rats, Wistar; Ubiquinone | 2016 |
Epigallocatechin gallate and coenzyme Q10 attenuate cisplatin-induced hepatotoxicity in rats via targeting mitochondrial stress and apoptosis.
Topics: Animals; Apoptosis; Catechin; Chemical and Drug Induced Liver Injury; Cisplatin; Hepatocytes; Liver; Male; Mitochondria, Liver; Oxidative Stress; Rats; Rats, Wistar; Ubiquinone | 2021 |